ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo

Lath, D.L. orcid.org/0000-0001-5454-9419, Buckle, C.H., Evans, H.R. et al. (4 more authors) (2018) ARQ-197, a small-molecule inhibitor of c-Met, reduces tumour burden and prevents myeloma-induced bone disease in vivo. PLoS One, 13 (6). e0199517. ISSN 1932-6203

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2018 Lath et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Dates:
  • Accepted: 9 June 2018
  • Published: 20 June 2018
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Funding Information:
FunderGrant number
BLOODWISE12053
BLOODWISE12053
Depositing User: Symplectic Sheffield
Date Deposited: 26 Jun 2018 12:55
Last Modified: 30 Oct 2018 14:22
Published Version: https://doi.org/10.1371/journal.pone.0199517
Status: Published
Publisher: Public Library of Science
Refereed: Yes
Identification Number: https://doi.org/10.1371/journal.pone.0199517
Related URLs:

Share / Export

Statistics